Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial

• Main Authors: Atsuhiro Kishimoto (Author), Maki Komiyama (Author), Hiromichi Wada (Author), Noriko Satoh-Asahara (Author), Hajime Yamakage (Author), Yoichi Ajiro (Author), Hiroki Aoyama (Author), Yasuhiro Katsuura (Author), Atsushi Imaizumi (Author), Tadashi Hashimoto (Author), Yoichi Sunagawa (Author), Tatsuya Morimoto (Author), Masashi Kanai (Author), Hideaki Kakeya (Author), Koji Hasegawa (Author)
• Format: Book
• Published: BMC, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Even after the peak of the COVID-19 pandemic, the number of mild cases remains high, requiring continuous control. Curcumin, owing to its anti-inflammatory properties, can suppress vital proliferation and cytokine secretion in animal models. We developed a highly absorbable cur...